(18)F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy

The ability to assess the distribution and extent of tau pathology in Alzheimer’s disease and progressive supranuclear palsy in vivo would help to develop biomarkers for these tauopathies and clinical trials of disease-modifying therapies. New radioligands for positron emission tomography have gener...

Descripción completa

Detalles Bibliográficos
Autores principales: Passamonti, Luca, Vázquez Rodríguez, Patricia, Hong, Young T., Allinson, Kieren S. J., Williamson, David, Borchert, Robin J., Sami, Saber, Cope, Thomas E., Bevan-Jones, W. Richard, Jones, P. Simon, Arnold, Robert, Surendranathan, Ajenthan, Mak, Elijah, Su, Li, Fryer, Tim D., Aigbirhio, Franklin I., O’Brien, John T., Rowe, James B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382948/
https://www.ncbi.nlm.nih.gov/pubmed/28122879
http://dx.doi.org/10.1093/brain/aww340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382948/
https://www.ncbi.nlm.nih.gov/pubmed/28122879
http://dx.doi.org/10.1093/brain/aww340

Ejemplares similares